← Back

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. The company provides anti-tumor drugs, gynecological medications, medication for rheumatic bone pain, urological medications, heat-clearing and detoxifying drugs, cardiovascular and cerebrovascular drugs, digestive medications, tonifying and restorative medicines, respiratory medication, diabetes medication, ENT medication, and pediatric medications. It also offers Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Xiongdan powder, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases. In addition, the company provides bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction. The company was founded in 1990 and is headquartered in Tonghua, China.

Price · split & dividend adjusted
News & notes moving 000766.CS
000766.CS3

Tonghua Golden Horse 2026 Interim Report Net Profit of 7.10 Million Yuan, Down 57.72% Year-on-Year

Tonghua Golden Horse released its 2026 interim report, with net profit attributable to the parent company of 7.10 million yuan, a decrease of 57.72% compared with the same period last year. The company's total operating revenue was 557 million yuan, down 14.28% year-on-year; net cash inflow from operating activities was 56.56 million yuan, down 27.53% year-on-year. The company's latest asset-liability ratio was 50.75%, gross margin was 75.31%, ROE was 0.31%, and diluted earnings per share was 0.01 yuan.
Jiemian·5dRead more ▾
Biotech & Genomic Medicine

Tonghua Jinma first-half net profit attributable to parent falls 57.7% year on year to 7.1 million yuan

Tonghua Jinma released its 2026 interim report, showing first-half net profit attributable to the parent fell 57.7% year on year to 7.1 million yuan. Operating revenue was 557 million yuan, down 14.3% year on year. Net profit attributable to the parent after deducting non-recurring items was 6.12 million yuan, down 57.5% year on year. Net operating cash flow was 56.56 million yuan, down 27.5% year on year. In the second quarter, net profit attributable to the parent was a loss of 2.02 million yuan, down 138.8% year on year. The company's self-developed succinic acid avicatonin tablets were approved for marketing in June 2026, becoming China's first self-developed innovative drug for the treatment of Alzheimer's disease.
财中社·6dRead more ▾
000766.CS4

Tonghua Golden Horse Plans to Acquire Controlling Stake in Innovative Drugmaker Ba Jia Yi Through Wholly-Owned Subsidiary

Tonghua Golden Horse announced that its wholly-owned subsidiary, Guilin Golden Horse Innovation Investment, has signed a letter of intent for a merger and acquisition with Ba Jia Yi Pharmaceutical, aiming to acquire a controlling stake in Ba Jia Yi. Founded in 2011, Ba Jia Yi is an innovative pharmaceutical company focused on original new drug research and development. It holds 23 drug R&D patents and has clinical trial approvals for two Class 1 chemical new drug candidates and one Class 1 traditional Chinese medicine new drug candidate.
证券时报·21dRead more ▾
000766.CS

Multiple Listed Companies Announce Positive Updates on the Evening of August 6

On the evening of August 6, several companies listed on the Shanghai and Shenzhen stock exchanges released significant positive announcements. Unitree Technology set its initial public offering price at 150.80 yuan per share, planning to list on the STAR Market. The offering size is 40.446434 million shares, accounting for 10 percent of the total post-IPO share capital, with online subscription scheduled for August 10. Tonghua Golden Horse intends to acquire a controlling stake in innovative drug company Bajia Yi through its wholly owned subsidiary Guilin Golden Horse. Bajia Yi holds 23 drug research and development patents and multiple clinical trial approvals for Class 1 new drugs. Zhongfu Shenying plans to raise no more than 3.893 billion yuan through a private placement to fund an annual production capacity of 30,000 tonnes of high-performance carbon fiber and other projects. Cre8 Direct plans to invest approximately 83.51 million yuan to acquire a 90 percent stake in Chuangku Future, advancing its designer toy and cultural creative business. Huaci Holdings stated that it has made the electrical ceramics business a key development focus, investing heavily this year in the construction of the Hualian Torch Electrical Ceramics Factory, which began trial production on June 11, with a healthy order backlog. Shengda Resources' controlled subsidiary Yindu Mining received approval for its technical renovation project to achieve an annual mining capacity of 900,000 tonnes. Songyuan Safety's wholly owned subsidiary secured a nomination from a European automaker to supply steering wheels and airbags, with a product lifecycle of seven years and estimated sales of approximately 691 million yuan. Hongchang Technology plans to acquire 45 percent stakes each in Kunwu Semiconductor and Youpin New Materials for no more than 405 million yuan and 315 million yuan respectively, with both companies focusing on lab-grown diamond materials. Mingjiahui plans to acquire up to a 26.19 percent stake in Zhiyu Technology for 263 million yuan in cash, expanding into the semiconductor industry. Wanwei High-tech plans to issue shares to its controlling shareholder Wanwei Group to raise no more than 2.3 billion yuan for polyvinyl alcohol resin and optical film projects.
Eastmoney·21dRead more ▾
000766.CS

Multiple Shanghai and Shenzhen Listed Companies Issue Key Announcements on the Evening of August 6

On the evening of August 6, multiple listed companies on the Shanghai and Shenzhen stock exchanges issued important announcements. Tongyu Communication clarified that the target company it plans to acquire, Jiaxian Communication, has no research and development partnership with Nvidia. Jiaxian Communication is conducting 6G AI-RAN base station research and development based on Nvidia's open-source platform, and there is significant uncertainty as to whether its subsequent products will gain market acceptance. The Xiqu Mine of Shanxi Coking Coal has been shut down after a safety production accident resulted in one fatality. The mine has an approved annual capacity of 2.7 million tonnes, accounting for 5.67 percent of the company's total capacity. Unitree Technology has set its initial public offering price at 150.80 yuan per share, with an offering size of 40.4464 million shares, and the online subscription date is August 10. Tonghua Golden Horse plans to acquire a controlling stake in the innovative pharmaceutical company Bajia Yi through a wholly-owned subsidiary. Bajia Yi holds multiple clinical trial approvals for Class 1 new drugs. Xingfa Group plans to raise no more than 3 billion yuan through a private placement, to be used for phosphate mining and beneficiation projects and loan repayment, with the controlling shareholder intending to subscribe for 100 million to 200 million yuan. China Rare Earth Nonferrous Metals plans to transfer a 37 percent stake in Dongdianhua Company through a public listing at a minimum price of 142 million yuan to optimize its asset structure. Baoding Technology clarified that its copper clad laminates and electronic copper foil products currently cannot be applied in AI servers or computing fields. Zhongfu Shenying plans to raise no more than 3.893 billion yuan through a private placement for projects including high-performance carbon fiber. Bojie Shares clarified regarding market rumors that its investee company Dingtai Xinyuan has incurred losses for three consecutive years, and its optical communication indium phosphide business has little impact on the company's performance. The AI server testing business accounts for 16.79 percent of revenue, liquid cooling modules have not been shipped independently, and the humanoid robot business is still in its early stages. Baihehua stated that photoresist pigment sales revenue in 2025 accounted for only 0.084 percent of the company's total revenue. Transsion Holdings' H-share issuance has been filed with the China Securities Regulatory Commission. Chuangyuan Shares plans to invest approximately 83.51 million yuan to acquire a 90 percent stake in Chuangku Future, expanding into the designer toy and cultural creative business. Huaci Shares has made the electrical ceramics business a key development direction, investing heavily this year in the construction of an electrical ceramics factory which has already been ignited and put into production. Shengda Resources' subsidiary Yindu Mining has received approval for a 900,000-tonne-per-year mining technical renovation project. STAR Cuihua faces delisting risk as its closing market value fell below 500 million yuan for the first time, and it may also trigger mandatory delisting for major violations due to suspected false financial records. Hongchang Technology plans to acquire 45 percent stakes each in Kunwu Semiconductor and Youpin New Materials for cash, with transaction prices not exceeding 405 million yuan and 315 million yuan respectively. Both companies focus on lab-grown diamond materials. Mingjiahui plans to purchase no more than a 26.19 percent stake in Zhiyu Technology for 263 million yuan, entering the semiconductor industry. Wanwei High-tech plans to raise no more than 2.3 billion yuan through a private placement to its controlling shareholder for polyvinyl alcohol resin and optical film projects. Weichai Power stated on an interactive platform that the company has no business related to recoverable aircraft engines. In terms of financial performance, Haodangjia reported first-half net profit of 29.9788 million yuan, up 21.74 percent year-on-year. Jianfan Biotech reported net profit of 382 million yuan, down 1.99 percent. Luchang Technology posted a loss of 22.0208 million yuan, narrowing its losses. Zhenghe Technology's July hog sales revenue was 5.404 million yuan, down 79.23 percent year-on-year. Lihua Shares' July broiler chicken sales revenue was 1.274 billion yuan, up 5.2 percent month-on-month. Jinhui Mining reported first-half net profit of 409 million yuan, up 61.52 percent year-on-year, and plans a dividend of 3.3 yuan per 10 shares. BioMap expects first-half net profit between 236 million and 246 million yuan, up 391.87 percent to 412.71 percent. Zongyi Shares reported net profit of 47.1374 million yuan, up 136.92 percent. Wenzhou Hongfeng reported net profit of 92.3462 million yuan, turning losses into gains. Jin Qilin reported net profit of 17.2938 million yuan, down 83.94 percent. Bailong Dongfang reported net profit of 559 million yuan, up 43.45 percent, and plans a dividend of 1.8 yuan per 10 shares. Pengding Holdings' July consolidated revenue was 3.201 billion yuan, up 6.61 percent year-on-year. Shennong Group's July commercial hog sales revenue was 411 million yuan, up 25.69 percent. Daodaoquan reported net profit of 16.8606 million yuan, down 90.68 percent, and plans a dividend of 0.49 yuan per 10 shares. Shenchengjiao reported net profit of 38.5445 million yuan, turning losses into gains. Weixing New Materials reported net profit of 390 million yuan, up 43.9 percent. Trina Solar reported a net loss of 270 million yuan, significantly narrowing its losses. Anjiesi reported net profit of 118 million yuan, down 6.27 percent. Regarding shareholding changes, Langhong Technology's actual controller, directors, and senior management plan to collectively reduce their holdings by no more than 1.994 percent. Faben Information has received a commitment for a special repurchase loan of no more than 60 million yuan. Jichuan Pharmaceutical's directors and CFO plan to collectively reduce their holdings by no more than 181,000 shares. Yangfan New Materials plans to repurchase shares for 30 million to 60 million yuan. Puyuan Shares has received a repurchase loan commitment letter for no more than 45 million yuan. Lianhua Holdings has obtained a repurchase loan commitment letter for no more than 90 million yuan. Shuanglin Shares plans to repurchase shares for 50 million to 100 million yuan. Only Education's shareholder Shanghai Changjia Investment plans to reduce its holdings by no more than 3 percent. In terms of major contracts, a wholly-owned subsidiary of Oled has won a bid for an AMOLED production line upgrade project worth 47.2815 million yuan. A wholly-owned subsidiary of Songyuan Safety has received a project nomination worth approximately 691 million yuan. Anhui Construction Engineering's new contract value for engineering construction business in the first half of the year was 42.617 billion yuan. A controlling subsidiary of Sanxing Electric has signed an overseas operation contract worth approximately 175 million yuan.
Eastmoney·21dRead more ▾